The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 09, 2014

Filed:

Aug. 17, 2010
Applicants:

Natalie A. Hawryluk, San Diego, CA (US);

J. Guy Breitenbucher, Escondido, CA (US);

William M. Jones, San Diego, CA (US);

Alison L. Chambers, San Diego, CA (US);

John M. Keith, San Diego, CA (US);

Mark Seierstad, Escondido, CA (US);

Inventors:

Natalie A. Hawryluk, San Diego, CA (US);

J. Guy Breitenbucher, Escondido, CA (US);

William M. Jones, San Diego, CA (US);

Alison L. Chambers, San Diego, CA (US);

John M. Keith, San Diego, CA (US);

Mark Seierstad, Escondido, CA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 239/42 (2006.01); C07D 403/12 (2006.01); A61K 31/506 (2006.01); C07D 417/12 (2006.01); C07D 413/04 (2006.01); C07D 409/12 (2006.01); C07D 409/04 (2006.01); C07D 401/04 (2006.01); C07D 413/12 (2006.01); C07D 405/12 (2006.01); C07D 405/04 (2006.01);
U.S. Cl.
CPC ...
C07D 239/42 (2013.01); C07D 417/12 (2013.01); C07D 413/04 (2013.01); C07D 409/12 (2013.01); C07D 409/04 (2013.01); C07D 401/04 (2013.01); C07D 403/12 (2013.01); C07D 413/12 (2013.01); C07D 405/12 (2013.01); C07D 405/04 (2013.01);
Abstract

Certain ethylene diamine compounds of Formula (I) are described, which are useful as FAAH inhibitors. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by fatty acid amide hydrolase (FAAH) activity, such as anxiety, pain, inflammation, sleep disorders, eating disorders, energy metabolism disorders, and movement disorders (e.g., multiple sclerosis). Methods of synthesizing such compounds are also disclosed.


Find Patent Forward Citations

Loading…